Journal
Frontiers in Cell and Developmental Biology
Publication Date
1-1-2022
Volume
10
First Page
1059938
Document Type
Open Access Publication
DOI
10.3389/fcell.2022.1059938
Rights and Permissions
Verbinnen I, Procknow SS, Lenaerts L, Reynhout S, Mehregan A, Ulens C, Janssens V and King KA (2022) Clinical and molecular characteristics of a novel rare de novo variant in PPP2CA in a patient with a developmental disorder, autism, and epilepsy. Front. Cell Dev. Biol. 10:1059938. doi: 10.3389/fcell.2022.1059938 © 2022 Verbinnen, Procknow, Lenaerts, Reynhout, Mehregan, Ulens, Janssens and King. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Recommended Citation
Verbinnen, Iris; Procknow, Sara S; Lenaerts, Lisa; Reynhout, Sara; Mehregan, Aujan; Ulens, Chris; Janssens, Veerle; and King, Katherine A, "Clinical and molecular characteristics of a novel rare de novo variant in PPP2CA in a patient with a developmental disorder, autism, and epilepsy." Frontiers in Cell and Developmental Biology. 10, 1059938 (2022).
https://digitalcommons.wustl.edu/oa_4/2533
